Skip to main content
. Author manuscript; available in PMC: 2009 Apr 15.
Published in final edited form as: Clin Cancer Res. 2008 Apr 15;14(8):2371–2377. doi: 10.1158/1078-0432.CCR-07-4368

Figure 2.

Figure 2

Kaplan-Maier survival probability curves comparing CCND1 G870A genotypes in patients with HNSCC both overall and stratified by tumor stage. The difference between the groups was tested by use of the log-rank method. (A) CCND1 G870A genotype (AA vs. GG/GA) in all patients (log-rank P<0.05); (B) CCND1 G870A genotype (AA vs. GG/GA) in low stage (1/2) patients (log-rank P<1.0); (C) CCND1 G870A genotype (AA vs. GG/GA) in high stage (3/4) patients (log-rank P<0.06). Survival time is defined as the time from initial diagnosis to patient’s death. Tick marks represent censored values.